(Reuters) -California is suing the United States’ leading insulin makers and pharmacy benefit managers, accusing them of using their market power to overcharge patients for the life-saving drug, the state’s attorney general announced on Thursday.The lawsuit, filed in California Superior Court in Los Angeles, targets Eli Lilly and Co, Novo Nordisk A/S and Sanofi SA, which together make more than 90% of the insulin drugs sold globally.It also names the three largest pharmacy benefit managers (PBMs) – UnitedHealth Group Inc’s Optum unit, CVS Health Corp’s CVS Caremark and Cigna Corp’s Express Scripts. PBMs maintain the lists of drugs covered by health insurance plans and negotiate prices with manufacturers, and the top three account for about 80% of the market.
Source: California lawsuit accuses drugmakers, pharmacy benefit managers of insulin overcharging
Post Views: 37
IronWynch
My pronouns are whatever you're comfortable with as long as you speak to me with respect. I'm an Afruikan and Iswa refugee living in Canaan. That's African American expat in Israel in Normalian. I build websites, make art, and assist people in exercising their spirituality. I'm also the king of an ile, Baalat Teva, a group of African spirituality adherents here. Feel free to contact me if you are in need of my services or just want to chat.
